In June 2022, the Government of Canada established a long-term agreement with Moderna for the domestic production of messenger RNA (mRNA) vaccines in Canada.
Novo Nordisk Canada Inc.
At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions.
Novo Nordisk Canada Inc. is an affiliate of Novo Nordisk A/S, a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: hemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 50,000 people in 80 countries and markets its products in 170 countries.